WeVote

Bill

Bill

HB 278

Pharmacists, allow to dispense ivermectin without a prescription

2025 Regular Session Introduced by Phillip Rigsby

Alabama bill allows pharmacists to sell ivermectin without prescription, eliminating physician oversight for a drug with limited proven human uses.

Read for the first time and referred to the House Committee on Health
0
WeVote Research Nonpartisan
Bill Summary · HB 278

Legislative bill overview

HB 278 would authorize Alabama pharmacists to dispense ivermectin without a prescription. Currently, ivermectin requires a doctor's prescription for human use, though it is FDA-approved for specific parasitic infections. This bill would remove that prescription requirement, allowing direct-to-consumer access through pharmacies.

Why is this important

This represents a significant expansion of pharmacist authority and patient access to a specific medication. The real-world impact depends heavily on implementation—it could improve access for patients with legitimate parasitic infections but also removes a medical gatekeeping mechanism that currently requires professional diagnosis before use.

Potential points of contention

  • Medical oversight concerns: Removing the prescription requirement eliminates physician diagnosis and monitoring, raising safety questions about off-label use, drug interactions, and appropriate dosing for individual patients
  • COVID-era context: Ivermectin gained prominence as an unproven COVID-19 treatment; this bill may be perceived as enabling use for unapproved purposes despite FDA warnings against such use
  • Pharmacist scope of practice: Represents a shift in whether pharmacists should diagnose conditions or only dispense under medical direction—a broader professional debate with resource and liability implications
  • Quality control and counterfeit risk: Over-the-counter access could increase circulation of counterfeit or substandard products without professional verification

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.